RECENT MEDIA RELEASES
Pfizer to Provide NZ with 60,000 Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19
Pfizer and BioNTech to Supply New Zealand with their Vaccine Against COVID-19
Media Enquiries
Accredited journalists can contact the Pfizer Australia & New Zealand Media Relations team at: mediaanz@pfizer.com.
Please note that this email address is intended specifically for journalists with media enquiries and unfortunately, we are unable to respond to any non-media enquiries sent to this address.